Physician profile
Barry Scott Farber
NPI 1073515151
$2,084.68
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,745 · 2020: $158 · 2021: $182.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,481.20 | 2019-2020 | |
| Astellas Pharma US INC | $201.82 | 2019-2020 | |
| Boston Scientific Corporation | $199.48 | 2019-2021 | |
| Janssen Biotech, INC. | $38.81 | 2019 | |
| Allergan, INC. | $38.15 | 2019 | |
| Rochester Medical Corporation | $33.62 | 2020 | |
| Pfizer INC. | $27.49 | 2019 | |
| Blue Earth Diagnostics | $21.89 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.45 | 2019 | |
| Amgen INC. | $13.96 | 2019 | |
| Travere Therapeutics, INC. | $13.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Farber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.